Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
MLSS Milestone Scientific
- 0.9100
- -0.0493-5.14%
Close May 7 16:00 ET
71.33MMarket Cap-15.17P/E (TTM)
0.9800High0.9100Low48.83KVolume0.9500Open0.9593Pre Close45.84KTurnover0.08%Turnover RatioLossP/E (Static)78.38MShares1.392652wk High12.30P/B56.02MFloat Cap0.575952wk Low--Dividend TTM61.56MShs Float90.3747Historical High--Div YieldTTM7.30%Amplitude0.1000Historical Low0.9380Avg Price1Lot Size
Milestone Scientific Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 45.18%-2.92M | -21.33%-1.51M | 7.53%-973.91K | 176.56%783.66K | 39.20%-1.22M | 11.70%-5.33M | -14.33%-1.25M | 7.72%-1.05M | 55.37%-1.02M | -32.91%-2M |
| Net income from continuing operations | 32.48%-4.71M | -4.03%-2.04M | 1.01%-1.46M | 110.03%223.64K | -9.19%-1.44M | 20.43%-6.98M | 1.52%-1.96M | 25.66%-1.48M | 22.65%-2.23M | 31.26%-1.32M |
| Depreciation and amortization | -10.56%134.84K | 6.44%33.96K | -15.57%33.21K | -20.65%31.52K | -9.17%36.15K | 4.43%150.77K | -7.68%31.9K | 19.69%39.34K | 2.84%39.73K | 3.86%39.8K |
| Other non cash items | -22.28%579.8K | 24.59%206.9K | -38.38%244.7K | 9.43%62.14K | -47.57%66.06K | -0.18%746K | -46.59%166.07K | 338.84%397.14K | --56.79K | --126K |
| Change In working capital | 54.94%-631K | -88.21%-156.66K | 46.69%-274.73K | -52.61%230.77K | 66.61%-430.38K | -154.76%-1.4M | -4,519.37%-83.24K | -333.59%-515.35K | 172.44%486.95K | -1,237.54%-1.29M |
| -Change in receivables | -145.68%-162.71K | -70.84%78.61K | -191.59%-167.15K | 123.91%275K | -59.67%-349.17K | 42.73%356.19K | -45.87%269.56K | 289.29%182.5K | -48.45%122.82K | 43.97%-218.68K |
| -Change in inventory | 2.61%-1.08M | 99.48%-1.58K | 4.06%-382.54K | -203.09%-469.07K | 9.81%-221.84K | -32.50%-1.1M | 22.45%-304.41K | -759.19%-398.73K | -13.99%-154.77K | 4.81%-245.96K |
| -Change in prepaid assets | 141.14%49.43K | -146.96%-182.47K | 183.08%368.12K | 196.31%259.15K | -158.27%-395.38K | -42.11%-120.16K | 33.75%388.58K | -570.92%-443.11K | 127.81%87.46K | 1.05%-153.08K |
| -Change in payables and accrued expense | 245.09%652.3K | 93.70%-26.42K | -141.59%-69.18K | -58.10%189.9K | 185.88%558K | -335.69%-449.59K | -10.72%-419.46K | -41.30%166.36K | 202.94%453.28K | -189.44%-649.77K |
| -Change in other current assets | -14.37%-94.99K | -41.64%-24.8K | -7.25%-23.99K | -10.84%-24.21K | -3.08%-21.99K | -14.79%-83.05K | 7.55%-17.51K | -58.95%-22.37K | ---21.84K | ---21.33K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 45.18%-2.92M | -21.33%-1.51M | 7.53%-973.91K | 176.56%783.66K | 39.20%-1.22M | 11.70%-5.33M | -14.33%-1.25M | 7.72%-1.05M | 55.37%-1.02M | -32.91%-2M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 199.81%2.97M | 99.31%-3.53K | 0 | -60.58%965.51K | 145.23%2M | -34,756.01%-2.97M | -10,842.60%-514.3K | -12,054.75%-475.49K | 2,881,311.76%2.45M | -4.43M |
| Net PPE purchase and sale | -107.42%-10.12K | 4.36%-3.53K | --0 | -164,800.00%-6.6K | --0 | 42.76%-4.88K | 21.51%-3.69K | 100.10%4 | -104.71%-4 | ---1.19K |
| Net investment purchase and sale | 200.31%2.98M | --0 | --0 | -60.31%972.11K | 145.24%2M | ---2.97M | ---510.61K | ---475.5K | --2.45M | ---4.43M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 199.81%2.97M | 99.31%-3.53K | --0 | -60.58%965.51K | 145.23%2M | -34,756.01%-2.97M | -10,842.60%-514.3K | -12,054.75%-475.49K | 2,881,311.76%2.45M | ---4.43M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -90.87%233.77K | -100.10%-2.52K | -20.03%-2.6K | -17.48%-2.54K | 11,266.93%241.43K | 30,071.15%2.56M | 124,843.49%2.57M | 4.00%-2.16K | 0.41%-2.16K | -4.80%-2.16K |
| Net issuance payments of debt | -8.22%-10.14K | 12.40%-2.52K | -20.03%-2.6K | -17.48%-2.54K | -14.62%-2.48K | -9.62%-9.37K | -39.94%-2.88K | 4.00%-2.16K | 0.41%-2.16K | -4.80%-2.16K |
| Net common stock issuance | -92.52%192.16K | --0 | --0 | --0 | --192.16K | --2.57M | --2.57M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --51.75K | --0 | --0 | --0 | --51.75K | --0 | --0 | ---- | ---- | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -90.87%233.77K | -100.10%-2.52K | -20.03%-2.6K | -17.48%-2.54K | 11,266.93%241.43K | 30,071.15%2.56M | 124,843.49%2.57M | 4.00%-2.16K | 0.41%-2.16K | -4.80%-2.16K |
| Net cash flow | ||||||||||
| Beginning cash position | -65.83%2.98M | 120.01%4.78M | 55.40%5.75M | 75.84%4.01M | -65.83%2.98M | -40.97%8.72M | -77.88%2.17M | -66.22%3.7M | -82.81%2.28M | -40.97%8.72M |
| Current changes in cash | 104.89%280.35K | -288.02%-1.52M | 36.21%-976.51K | 22.70%1.75M | 115.97%1.03M | 5.15%-5.74M | 173.62%807.12K | -33.41%-1.53M | 162.01%1.42M | -326.43%-6.44M |
| End cash Position | 9.41%3.26M | 9.41%3.26M | 120.01%4.78M | 55.40%5.75M | 75.84%4.01M | -65.83%2.98M | -65.83%2.98M | -77.88%2.17M | -66.22%3.7M | -82.81%2.28M |
| Free cash flow | 45.04%-2.93M | -21.25%-1.52M | 7.53%-973.91K | 175.92%777.06K | 39.24%-1.22M | 11.75%-5.33M | -14.18%-1.25M | 8.03%-1.05M | 55.37%-1.02M | -32.99%-2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call